Tenax Therapeutics Inc <TENX.O>: Canaccord Genuity initiates coverage with buy rating; target price $35
TENX•Related News
Coca-Cola, battling high aluminium costs, loses market share in India
KO•
India Competition Regulator Approves Acquisition Of Units By Brookfield Asset Management Of Oaktree Capital Group Holdings, Oaktree Equity Plan
BAM•
HF Sinclair posts highest profit since 2022, plans lubricants unit spin-off
DINO•
Marcus & Millichap brokers sale of 71-room Holiday Inn Express & Suites in Temple, Texas
MMI•
Nasdaq trade halt continues <QMMM.O> reason not available at 10:43 AM
QMMM•